Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Covidien launches new technology on Dräger's monitor in Europe

This article was originally published in Clinica

Executive Summary

Covidien has made its NellCor OxiMax technology available on Dräger's Infinity acute care system in Europe. Dräger's device integrates patient monitoring, therapy and IT across the whole healthcare system, and includes the portable Infinity M540 monitor. The new technology will add Nellcor OxiMax speciality pulse oximetry sensors and Nellcor SatSeconds alarm management technology to the Infinity system. Pulse oximetry is used to noninvasively measure patients' oxygenation saturation levels, while SatSeconds will generate “smart alarms” based on the severity of desaturation.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT096418

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel